46
V. Dekaris, H.-U. Reissig
LETTER
(4) Bressel, B.; Egart, B.; Al-Harrasi, A.; Pulz, R.; Reissig,
H.-U.; Brüdgam, I. Eur. J. Org. Chem. 2008, 467.
(5) Bressel, B.; Reissig, H.-U. Org. Lett. 2009, 11, 527.
(6) (a) Pulz, R.; Watanabe, T.; Schade, W.; Reissig, H.-U.
Synlett 2000, 983. (b) Pulz, R.; Al-Harrasi, A.; Reissig,
H.-U. Org. Lett. 2002, 4, 2353.
(7) (a) Keck, G. E.; McHardy, S. F.; Wager, T. T. Tetrahedron
Lett. 1995, 36, 7419. (b) Chiara, J. L.; Destabel, C.; Gallego,
P.; Marco-Contelles, J. J. Org. Chem. 1996, 61, 359.
(c) Revuelta, J.; Cicchi, S.; Brandi, A. Tetrahedron Lett.
2004, 45, 8375. (d) Young, I. S.; Williams, J. L.; Kerr, M. A.
Org. Lett. 2005, 7, 953.
(8) (a) Krämer, B.; Franz, T.; Picasso, S.; Pruschek, P.; Jäger, V.
Synlett 1997, 295. For selected review articles on glyco-
sidase inhibition in general, see: (b) Iminosugars as
Glycosidase Inhibitors; Stütz, A. E., Ed.; Wiley-VCH:
Weinheim, 1999. (c) Zechel, D. L.; Withers, S. G. Acc.
Chem. Res. 2000, 33, 11. (d) Lillelund, V. H.; Jensen, H. H.;
Liang, X.; Bols, M. Chem. Rev. 2002, 102, 515.
(e) Winchester, B. G. Tetrahedron: Asymmetry 2009, 20,
645. (f) Davis, B. G. Tetrahedron: Asymmetry 2009, 20,
652.
d = 1.34 (s, 6 H, Me), 2.97 (dd, J = 3.2, 8.1 Hz, 1 H, 4-H),
3.66–3.74 (m, 5 H, 1-H, 3-H, 5¢-HA, NCH2), 3.88 (mc, 1 H,
2-H), 3.93 (d, J = 13.1 Hz, 1 H, NCH2), 3.98–4.03 (m, 1 H,
5¢-HB), 4.35 (mc, 1 H, 4¢-H), AB-system (dA = 4.49,
dB = 4.55, J = 11.5 Hz, 2 H, OCH2Ph), 7.22–7.36 (m, 10 H,
Ph) ppm. OH and NH could not be assigned. 13C NMR (126
MHz, CDCl3): d = 25.6, 26.7 (2 q, Me), 51.9 (t, NCH2), 60.7
(d, C-4), 63.5 (t, C-1), 67.7 (t, C-5¢), 72.6 (d, C-2), 72.8 (d,
C-3), 73.1 (t, OCH2Ph), 75.3 (d, C-4¢), 108.5 (s, C-2¢), 127.5,
128.0, 128.1, 128.2, 137.5, 138.7 (4 d, 2 s, Ph) ppm. IR
(KBr): 3420, 3310 (OH, NH), 3085–3030 (=CH), 2985–
2855 (CH) cm–1. HRMS (ESI-TOF-MS): m/z calcd for
C23H31NO5 [M + H]+: 402.2275; found: 402.2280.
(14) This result may be improved since the reaction was only
performed once and samarium(II) was consumed mostly
before completion of the reaction probably by traces of air
indicated by the greenish colour of the solution.
(15) Typical Procedure for Ring Closure of 4a to 5a
To a solution of 4a (697 mg, 1.35 mmol) in pyridine (50 mL)
under argon at r.t. MsCl (0.15 mL, 1.94 mmol) was added.
The mixture was stirred 1 d at r.t. and 3 d at 50 °C. After
quenching with 5% CuSO4 solution (50 mL) the mixture was
extracted three times with Et2O, the combined organic layers
were washed twice with H2O, and dried with MgSO4. After
filtration and removal of the solvents, purification via silica
gel column chromatography (hexane–EtOAc) afforded 5a
(565 mg, 84%) as a colourless oil.
(9) For review articles, see: (a) Cromwell, N. H.; Phillips, B.
Chem. Rev. 1979, 79, 331. (b) Brandi, A.; Cicchi, S.;
Cordero, F. M. Chem. Rev. 2008, 108, 3988.
(10) So far we do not know at which stage of the hydroboration
process the N–O bond cleavage occurs.
(11) (a) Mitsunobu, O.; Yamada, M. Bull. Chem. Soc. Jpn. 1967,
40, 2380. (b) Mitsunobu, O. Synthesis 1981, 1. (c) Yuen,
T.; But, S.; Toy, P. H. Chem. Asian J. 2007, 2, 1340.
(d) For a recent review, see: Kumara Swamy, K. C.;
Bhuvan Kumar, N. N.; Balaraman, E.; Pavan Kumar,
K. V. P. Chem. Rev. 2009, 109, 2551.
(12) Dess, D. B.; Martin, J. C. J. Am. Chem. Soc. 1991, 113, 7277.
(13) Typical Procedure for Ring Cleavage of 2d to 3b
To a suspension of samarium (1.98 g, 13.2 mmol) in THF
(20 mL) under argon at r.t. 1,2-diiodoethane (2.65 g, 9.40
mmol) was added. The mixture was stirred for 2 h at r.t. and
turned to a dark blue colour. Afterwards 1,2-oxazine 2d
(1.50 g, 3.75 mmol) was dissolved in THF (20 mL) and
added slowly to the SmI2 solution. The mixture was stirred
for 4 h at r.t., then quenched with sat. NaHCO3 solution,
extracted three times with Et2O, and the combined organic
layers were dried with MgSO4. After filtration and removal
of the solvent recrystallization with a mixture of hexane and
EtOAc afforded 3b (1.27 g, 84%) as a colourless solid (mp
94–96 °C).
Analytical Data of (2S,3S,4R,4¢S)-1-Benzyl-3-benzyloxy-
2-(tert-butyldimethylsiloxymethyl)-4-(2¢,2¢-dimethyl-
1¢,3¢-dioxolan-4¢-yl)azetidine (5a)
[a]D20 +12.3 (c 0.9, CHCl3). 1H NMR (500 MHz, CDCl3):
d = 0.00 (s, 6 H, SiMe2), 0.83 (s, 9 H, Sit-Bu), 1.32, 1.35 (2
s, 6 H, Me), 2.95–3.35 (m, 2 H, 4-CH2), 3.49 (mc, 1 H, 4-H),
3.85 (mc, 1 H, 2-H), 4.03 (dd, J = 4.6, 7.3 Hz, 1 H, 3-H),
3.75, 4.18 (2 d, J = 12.7 Hz, 2 H, NCH2), 4.34, 4.60 (2 d,
J = 11.9 Hz, 2 H, OCH2Ph), 4.23 (mc, 2 H, 5¢-H), 4.81 (mc,
1 H, 4¢-H), 7.20–7.36 (m, 10 H, Ph) ppm. 13C NMR (126
MHz, CDCl3): d = –5.54, –5.52 (2 q, SiMe2), 18.2, 25.9 (s,
q, Sit-Bu), 25.5, 26.7 (2 q, Me), 55.7 (t, NCH2), 64.2 (t, 4-
CH2), 67.9 (t, C-5¢), 69.1 (d, C-2), 71.1 (t, OCH2Ph), 72.3 (d,
C-4), 73.9 (d, C-4¢), 74.2 (d, C-3), 108.6 (s, C-2¢), 127.3,
127.5, 128.0, 128.3, 128.5, 128.7 (6 d, Ph), 138.2, 140.1 (2
s, Ph) ppm. IR (film): 3085-3030 (=CH), 2985–2855 (CH)
cm–1. MS (EI, 80 eV, 90 °C): m/z (%) = 497 (2) [M+], 482 (4)
[M – CH3]+, 406 (26) [M – C7H7]+, 396 (54) [M – C5H9O2]+,
91 (100) [C7H7]+. Anal. Calcd for C29H43NO4Si (497.7): C,
69.98; H, 8.71; N, 2.81. Found: C, 69.72; H, 8.61; N, 2.62.
(16) The constitution and configuration of compound 7a was
unequivocally proven by an X-ray analysis: Brüdgam, I.;
Institut für Chemie und Biochemie, Freie Universität Berlin,
unpublished results.
Analytical Data of (2S,3R,4S,4¢S)-4-Benzylamino-3-
benzyloxy-4-(2¢,2¢-dimethyl-1¢,3¢-dioxolan-4¢-yl)butane-
1,2-diol (3b)
[a]D20 –25.6 (c 0.40, CHCl3). 1H NMR (500 MHz, CDCl3):
Synlett 2010, No. 1, 42–46 © Thieme Stuttgart · New York